The recognition that mesenchymal stem cells can modify immune functions has piqued interest in developing cells to treat a range of musculoskeletal abnormalities, cardiac disease, and some immune abnormalities. The challenges of identifying, isolating, differentiating, and expanding these cells has limited widespread adoption to date. Still, Corning is committed to enabling advancement in this important research area. We offer a wide range of platforms and surface technologies to help drive your stem cell therapy research forward, including:
- Pre-coated, high-density vessels for the reproducible expansion of adherent or suspension-based stem cell cultures
- Customizable closed system options that eliminate open fluid manipulation
- Specialized, xeno-free surfaces, media, and reagents to address stem cell research, providing you with a single supplier for your work with MSCs, ESCs, iPSCs, and NSCs
- Customizable options in vessels, surfaces, and media to meet your requirements